In the latest session, Olema Pharmaceuticals Inc (NASDAQ: OLMA) closed at $13.00 down -7.60% from its previous closing price of $14.07. In other words, the price has decreased by -$1.07 from its previous closing price. On the day, 564002 shares were traded.
Ratios:
For a deeper understanding of Olema Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.66 and its Current Ratio is at 17.66. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on January 30, 2024, initiated with a Buy rating and assigned the stock a target price of $20.
On July 21, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $21.
On May 05, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $16.CapitalOne initiated its Overweight rating on May 05, 2023, with a $16 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 29 ’24 when Harmon Cyrus sold 25,000 shares for $12.41 per share. The transaction valued at 310,309 led to the insider holds 846,283 shares of the business.
Harmon Cyrus sold 5,000 shares of OLMA for $77,800 on Feb 01 ’24. The Director now owns 871,283 shares after completing the transaction at $15.56 per share. On Jan 31 ’24, another insider, Harmon Cyrus, who serves as the Director of the company, sold 25,000 shares for $12.23 each. As a result, the insider received 305,750 and left with 876,283 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OLMA now has a Market Capitalization of 716.81M and an Enterprise Value of 442.54M.
Stock Price History:
Over the past 52 weeks, OLMA has reached a high of $17.79, while it has fallen to a 52-week low of $3.00. The 50-Day Moving Average of the stock is 13.36, while the 200-Day Moving Average is calculated to be 11.56.
Shares Statistics:
For the past three months, OLMA has traded an average of 759.99K shares per day and 633.67k over the past ten days. A total of 55.10M shares are outstanding, with a floating share count of 47.61M. Insiders hold about 13.59% of the company’s shares, while institutions hold 86.02% stake in the company. Shares short for OLMA as of Feb 15, 2024 were 6.18M with a Short Ratio of 8.14, compared to 7.08M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.22% and a Short% of Float of 15.11%.
Earnings Estimates
There are 9 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.48 for the current quarter, with a high estimate of -$0.4 and a low estimate of -$0.65, while EPS last year was -$0.65. The consensus estimate for the next quarter is -$0.51, with high estimates of -$0.42 and low estimates of -$0.69.
Analysts are recommending an EPS of between -$1.99 and -$2.3 for the fiscal current year, implying an average EPS of -$2.12. EPS for the following year is -$2.19, with 8 analysts recommending between -$1.76 and -$2.75.
